The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers

P J Trainer, J Holly, S Medbak, L H Rees, G M Besser

Research output: Contribution to journalArticle (Academic Journal)peer-review

15 Citations (Scopus)

Abstract

Insulin-like growth factor-I is the mediator of many of the actions of GH and is a potent metabolic regulator. Recombinant IGF-I (rhIGF-I) is of potential value in the treatment of syndromes associated with either GH or insulin resistance. This study was designed to assess the effects of subcutaneous (s.c.) rhIGF-I on anterior pituitary function.
Original languageEnglish
Pages (from-to)801-7
Number of pages7
JournalClinical Endocrinology
Volume41
Issue number6
Publication statusPublished - 1994

Fingerprint Dive into the research topics of 'The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers'. Together they form a unique fingerprint.

Cite this